A. Sáenz

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro et al. · Journal of Clinical Oncology · 2005 · 231 citations

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium

Joaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2000 · 191 citations

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

Jorge Aparicio, Xavier García del Muro, Pablo Maroto et al. · Annals of Oncology · 2003 · 126 citations · Full text

Clinical Stage, Dual Policy, Surgical Oncology +8

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Annals of Oncology · 2014 · 122 citations · Full text

Prognostic Factors, Risk-adapted Studies, Urology +9

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract

Miquel Nogué‐Aliguer, Joan Carles, A. Arriví et al. · Cancer · 2003 · 98 citations · Full text